153 related articles for article (PubMed ID: 23927085)
1. Cytomegalovirus & Epstein Barr Virus serostatus as a predictor of the long-term outcome of kidney transplantation.
Le Page AK; Mackie FE; McTaggart SJ; Kennedy SE
Nephrology (Carlton); 2013 Dec; 18(12):813-9. PubMed ID: 23927085
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma.
Opelz G; Daniel V; Naujokat C; Döhler B
Transplantation; 2009 Oct; 88(8):962-7. PubMed ID: 19855238
[TBL] [Abstract][Full Text] [Related]
3. Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients.
Sampaio MS; Cho YW; Shah T; Bunnapradist S; Hutchinson IV
Nephrol Dial Transplant; 2012 Jul; 27(7):2971-9. PubMed ID: 22273720
[TBL] [Abstract][Full Text] [Related]
4. CMV mismatch does not affect patient and graft survival in UK renal transplant recipients.
Johnson RJ; Clatworthy MR; Birch R; Hammad A; Bradley JA
Transplantation; 2009 Jul; 88(1):77-82. PubMed ID: 19584684
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus serostatus pairing and deceased donor kidney transplant outcomes in adult recipients with antiviral prophylaxis.
Kuo HT; Ye X; Sampaio MS; Reddy P; Bunnapradist S
Transplantation; 2010 Nov; 90(10):1091-8. PubMed ID: 20885340
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of valganciclovir for prevention of infections with cytomegalovirus and Epstein-Barr virus after kidney transplant in children.
Cameron BM; Kennedy SE; Rawlinson WD; Mackie FE
Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27704725
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus mismatch still negatively affects patient and graft survival in the era of routine prophylactic and preemptive therapy: A paired kidney analysis.
Leeaphorn N; Garg N; Thamcharoen N; Khankin EV; Cardarelli F; Pavlakis M
Am J Transplant; 2019 Feb; 19(2):573-584. PubMed ID: 30431703
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Epstein-Barr virus (EBV) antibody screening of organ donors for allocation of organs to EBV serostatus matched recipients.
Lazda VA
Transplant Proc; 2006 Dec; 38(10):3404-5. PubMed ID: 17175286
[TBL] [Abstract][Full Text] [Related]
9. Is screening for IgG antibody to cytomegalovirus and Epstein-Barr virus infections mandatory in potential renal transplant recipients and donors in Iran?
Saghafi H; Qorashi M; Heidari A
Transplant Proc; 2009 Sep; 41(7):2761-3. PubMed ID: 19765428
[TBL] [Abstract][Full Text] [Related]
10. Multivariate analysis of the influence of donor and recipient cytomegalovirus sero-pairing on outcomes in simultaneous kidney-pancreas transplantation: the South-Eastern Organ Procurement Foundation Experience.
Stratta RJ; Thacker LR; Sundberg AK;
Transplant Proc; 2005 Mar; 37(2):1271-3. PubMed ID: 15848692
[TBL] [Abstract][Full Text] [Related]
11. Impact of Cytomegalovirus Serostatus on Allograft Loss and Mortality Within the First Year After Kidney Transplantation: An Analysis of the National Transplant Registry.
Bruminhent J; Dajsakdipon T; Ingsathit A; Supaporn T; Prommool S; Watcharananan SP
Transplant Proc; 2020 Apr; 52(3):829-835. PubMed ID: 32113693
[TBL] [Abstract][Full Text] [Related]
12. Revisiting cytomegalovirus serostatus and replication as risk factors for inferior long-term outcomes in the current era of renal transplantation.
Bischof N; Wehmeier C; Dickenmann M; Hirt-Minkowski P; Amico P; Steiger J; Naegele K; Hirsch HH; Schaub S
Nephrol Dial Transplant; 2020 Feb; 35(2):346-356. PubMed ID: 31943075
[TBL] [Abstract][Full Text] [Related]
13. Detection of viral DNA in kidney graft preservation and washing solutions is predictive of posttransplant infections in pediatric recipients.
Barzon L; Murer L; Pacenti M; Biasolo MA; Vella MD; Ghirardo G; Gamba PG; De Arias AE; Zanon GF; Palù G
J Infect Dis; 2009 Nov; 200(9):1425-33. PubMed ID: 19803803
[TBL] [Abstract][Full Text] [Related]
14. Association of Baseline Viral Serology and Sirolimus Regimens With Kidney Transplant Outcomes: A 14-Year Registry-Based Cohort Study in the United States.
Santos AH; Casey MJ; Xuerong W; Womer KL
Transplantation; 2017 Feb; 101(2):377-386. PubMed ID: 28121742
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-associated smooth muscle tumors after kidney transplantation: treatment and outcomes in a single center.
Tan CS; Loh HL; Foo MW; Choong LH; Wong KS; Kee TY
Clin Transplant; 2013; 27(4):E462-8. PubMed ID: 23682851
[TBL] [Abstract][Full Text] [Related]
16. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
[TBL] [Abstract][Full Text] [Related]
17. Donor and recipient CMV serostatus and antigenemia after renal transplantation: an analysis of 486 patients.
Hughes D; Hafferty J; Fulton L; Friend P; Devaney A; Loke J; Welsh KI; Handa A; Klenerman P
J Clin Virol; 2008 Feb; 41(2):92-5. PubMed ID: 18032098
[TBL] [Abstract][Full Text] [Related]
18. Early and late virological monitoring of cytomegalovirus, Epstein-Barr virus, and human herpes virus 6 infections in small bowel/multivisceral transplant recipients.
Petrisli E; Chiereghin A; Gabrielli L; Zanfi C; Lauro A; Piccirilli G; Baccolini F; Altimari A; Bagni A; Cescon M; Pinna AD; Landini MP; Lazzarotto T
Transplant Proc; 2010; 42(1):74-8. PubMed ID: 20172284
[TBL] [Abstract][Full Text] [Related]
19. Postlung transplant survival is equivalent regardless of cytomegalovirus match status.
Russo MJ; Sternberg DI; Hong KN; Sorabella RA; Moskowitz AJ; Gelijns AC; Wilt JR; D'Ovidio F; Kawut SM; Arcasoy SM; Sonett JR
Ann Thorac Surg; 2007 Oct; 84(4):1129-34; discussion 1134-5. PubMed ID: 17888958
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with the development of cytomegalovirus infection following solid organ transplantation.
da Cunha-Bang C; Sørensen SS; Iversen M; Sengeløv H; Hillingsø JG; Rasmussen A; Mortensen SA; Fox ZV; Kirkby NS; Christiansen CB; Lundgren JD
Scand J Infect Dis; 2011 May; 43(5):360-5. PubMed ID: 21306196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]